AI assistant
Tempest Therapeutics, Inc. — Director's Dealing 2021
Feb 9, 2021
34632_dirs_2021-02-09_0ede8f14-df26-42af-a5d2-e53601bad750.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: Millendo Therapeutics, Inc. (MLND)
CIK: 0001544227
Period of Report: 2021-02-01
Reporting Person: Minai-Azary Jennifer Lynn (Chief Financial Officer)
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Stock Option (right to buy) | $1.08 | 2023-08-21 | Common Stock (2969.0) | Direct | |
| Stock Option (right to buy) | $2.69 | 2024-05-27 | Common Stock (989.0) | Direct | |
| Stock Option (right to buy) | $4.44 | 2026-01-27 | Common Stock (12382.0) | Direct | |
| Stock Option (right to buy) | $8.47 | 2026-11-02 | Common Stock (12840.0) | Direct | |
| Stock Option (right to buy) | $16.4 | 2028-08-23 | Common Stock (11160.0) | Direct | |
| Stock Option (right to buy) | $10.48 | 2029-01-31 | Common Stock (18000.0) | Direct | |
| Stock Option (right to buy) | $11.59 | 2029-06-20 | Common Stock (7000.0) | Direct | |
| Stock Option (right to buy) | $7.94 | 2030-01-30 | Common Stock (20000.0) | Direct | |
| Stock Option (right to buy) | $2.0 | 2030-05-24 | Common Stock (20000.0) | Direct |
Footnotes
F1: Shares subject to this option are fully vested.
F2: Twenty-five percent (25%) of the shares subject to this option vested on August 20, 2019, and one thirty-sixth (1/36th) of the remaining shares subject to this option shall vest each month thereafter, subject to the Reporting Person continuing to provide service through each such date.
F3: Twenty-five percent (25%) of the shares subject to this option vested on January 31, 2020, and one thirty-sixth (1/36th) of the remaining shares subject to this option shall vest each month thereafter, subject to the Reporting Person continuing to provide service through each such date.
F4: Twenty-five percent (25%) of the shares subject to this option vested on June 20, 2020, and one thirty-sixth (1/36th) of the remaining shares subject to this option shall vest each month thereafter, subject to the Reporting Person continuing to provide service through each such date.
F5: Twenty-five percent (25%) of the shares subject to this option vested on January 31, 2021, and one thirty-sixth (1/36th) of the remaining shares subject to this option shall vest each month thereafter, subject to the Reporting Person continuing to provide service through each such date.
F6: Fifty percent (50%) of the shares subject to this option vested on December 31, 2020, and one twelfth (1/12th) of the remaining shares subject to this option shall vest in equal monthly installments thereafter, subject to the Reporting Person continuing to provide service to the Issuer through each such date.